GB Patent

GB9705361D0 — Chemical compounds

Assigned to Celltech R&D Ltd · Expires 1997-04-30 · 29y expired

What this patent protects

Patent listed against Inrebic.

Drugs covered by this patent

Inrebic (FEDRATINIB HYDROCHLORIDE) · Bristol-Myers Squibb

Patent Metadata

Patent number: GB9705361D0
Jurisdiction: GB
Classification: —
Expires: 1997-04-30
Drug substance claim: No
Drug product claim: No
Assignee: Celltech R&D Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.